The Challenge of Assessing Mild Neuroinflammation in Severe Mental Disorders

Recent psychoneuroimmunology research has provided new insight into the etiology and pathogenesis of severe mental disorders (SMDs). The mild encephalitis (ME) hypothesis was developed with the example of human Borna disease virus infection years ago and proposed, that a subgroup SMD patients, mainl...

Full description

Bibliographic Details
Main Author: Karl Bechter
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-08-01
Series:Frontiers in Psychiatry
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fpsyt.2020.00773/full
_version_ 1818290340796301312
author Karl Bechter
author_facet Karl Bechter
author_sort Karl Bechter
collection DOAJ
description Recent psychoneuroimmunology research has provided new insight into the etiology and pathogenesis of severe mental disorders (SMDs). The mild encephalitis (ME) hypothesis was developed with the example of human Borna disease virus infection years ago and proposed, that a subgroup SMD patients, mainly from the broad schizophrenic and affective spectrum, could suffer from mild neuroinflammation, which remained undetected because hard to diagnose with available diagnostic methods. Recently, in neurology an emerging new subgroup of autoimmune encephalitis (AE) cases suffering from various neurological syndromes was described in context with the discovery of an emerging list of Central Nervous System (CNS) autoantibodies. Similarly in psychiatry, consensus criteria of autoimmune psychosis (AP) were developed for patients presenting with CNS autoantibodies together with isolated psychiatric symptoms and paraclinical findings of (mild) neuroinflammation, which in fact match also the previously proposed ME criteria. Nevertheless, identifying mild neuroinflammation in vivo in the individual SMD case remains still a major clinical challenge and the possibility that further cases of ME remain still under diagnosed appears an plausible possibility. In this paper a critical review of recent developments and remaining challenges in the research and clinical diagnosis of mild neuroinflammation in SMDs and in general and in transdisciplinary perspective to psycho-neuro-immunology and neuropsychiatry is given. Present nosological classifications of neuroinflammatory disorders are reconsidered with regard to findings from experimental and clinical research. A refined grading list of clinical states including “classical” encephalitis, AE, AP/ME,and newly proposed terms like parainflammation, stress-induced parainflammation and neuroprogression, and their respective relation to neurodegeneration is presented, which may be useful for further research on the possible causative role of mild neuroinflammation in SMDs. Beyond, an etiology-focused subclassification of ME subtypes, like autoimmune ME or infectious ME, appears to be required for differential diagnosis and individualized treatment. The present status of the clinical diagnosis of mild neuroinflammatory mechanisms involved in SMDs is outlined with the example of actual diagnosis and therapy in AP. Ideas for future research to unravel the contribution of mild neuroinflammation in the causality of SMDs and the difficulties expected to come to novel immune modulatory, anti-infectious or anti-inflammatory therapeutic principles in the sense of precision medicine are discussed.
first_indexed 2024-12-13T02:26:37Z
format Article
id doaj.art-13558ff994b745d196149cfe0b20ce04
institution Directory Open Access Journal
issn 1664-0640
language English
last_indexed 2024-12-13T02:26:37Z
publishDate 2020-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Psychiatry
spelling doaj.art-13558ff994b745d196149cfe0b20ce042022-12-22T00:02:36ZengFrontiers Media S.A.Frontiers in Psychiatry1664-06402020-08-011110.3389/fpsyt.2020.00773520060The Challenge of Assessing Mild Neuroinflammation in Severe Mental DisordersKarl BechterRecent psychoneuroimmunology research has provided new insight into the etiology and pathogenesis of severe mental disorders (SMDs). The mild encephalitis (ME) hypothesis was developed with the example of human Borna disease virus infection years ago and proposed, that a subgroup SMD patients, mainly from the broad schizophrenic and affective spectrum, could suffer from mild neuroinflammation, which remained undetected because hard to diagnose with available diagnostic methods. Recently, in neurology an emerging new subgroup of autoimmune encephalitis (AE) cases suffering from various neurological syndromes was described in context with the discovery of an emerging list of Central Nervous System (CNS) autoantibodies. Similarly in psychiatry, consensus criteria of autoimmune psychosis (AP) were developed for patients presenting with CNS autoantibodies together with isolated psychiatric symptoms and paraclinical findings of (mild) neuroinflammation, which in fact match also the previously proposed ME criteria. Nevertheless, identifying mild neuroinflammation in vivo in the individual SMD case remains still a major clinical challenge and the possibility that further cases of ME remain still under diagnosed appears an plausible possibility. In this paper a critical review of recent developments and remaining challenges in the research and clinical diagnosis of mild neuroinflammation in SMDs and in general and in transdisciplinary perspective to psycho-neuro-immunology and neuropsychiatry is given. Present nosological classifications of neuroinflammatory disorders are reconsidered with regard to findings from experimental and clinical research. A refined grading list of clinical states including “classical” encephalitis, AE, AP/ME,and newly proposed terms like parainflammation, stress-induced parainflammation and neuroprogression, and their respective relation to neurodegeneration is presented, which may be useful for further research on the possible causative role of mild neuroinflammation in SMDs. Beyond, an etiology-focused subclassification of ME subtypes, like autoimmune ME or infectious ME, appears to be required for differential diagnosis and individualized treatment. The present status of the clinical diagnosis of mild neuroinflammatory mechanisms involved in SMDs is outlined with the example of actual diagnosis and therapy in AP. Ideas for future research to unravel the contribution of mild neuroinflammation in the causality of SMDs and the difficulties expected to come to novel immune modulatory, anti-infectious or anti-inflammatory therapeutic principles in the sense of precision medicine are discussed.https://www.frontiersin.org/article/10.3389/fpsyt.2020.00773/fullneuroinflammationmild encephalitisautoimmune encephalitisautoimmune psychosisBorna viruspsychoimmunology
spellingShingle Karl Bechter
The Challenge of Assessing Mild Neuroinflammation in Severe Mental Disorders
Frontiers in Psychiatry
neuroinflammation
mild encephalitis
autoimmune encephalitis
autoimmune psychosis
Borna virus
psychoimmunology
title The Challenge of Assessing Mild Neuroinflammation in Severe Mental Disorders
title_full The Challenge of Assessing Mild Neuroinflammation in Severe Mental Disorders
title_fullStr The Challenge of Assessing Mild Neuroinflammation in Severe Mental Disorders
title_full_unstemmed The Challenge of Assessing Mild Neuroinflammation in Severe Mental Disorders
title_short The Challenge of Assessing Mild Neuroinflammation in Severe Mental Disorders
title_sort challenge of assessing mild neuroinflammation in severe mental disorders
topic neuroinflammation
mild encephalitis
autoimmune encephalitis
autoimmune psychosis
Borna virus
psychoimmunology
url https://www.frontiersin.org/article/10.3389/fpsyt.2020.00773/full
work_keys_str_mv AT karlbechter thechallengeofassessingmildneuroinflammationinseverementaldisorders
AT karlbechter challengeofassessingmildneuroinflammationinseverementaldisorders